Cholestyramine

Product NDC
0245-0536
11-digit product format
002450536
Labeler code
0245
Product ID
0245-0536_46900dd9-d039-40e6-bef8-c2f6ce2981ff
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cholestyramine
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Labeler
Upsher-Smith Laboratories, Inc.
Application
ANDA074557
Marketing category
ANDA
Marketing start
1996-08-15
Marketing end
2023-09-30
Substance
CHOLESTYRAMINE
Active strength
4 g/9g
Pharmacologic classes
Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0245-0536-37GM - Gram0245-0536af095363-bfb1-41c3-bcd3-6ad83cc5932112012-07-24
0245-0536-60EA - Each0245-0536eb26aeab-6d90-4676-ac90-03129d5bd6b312012-07-24

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0245-0536-3700245053637378 g in 1 CAN (0245-0536-37) 378 g2012-01-052021-09-30NoNoCurrent
0245-0536-600024505366060 POUCH in 1 CARTON (0245-0536-60) > 9 g in 1 POUCH60 pouch2012-01-052023-09-30NoNoCurrent